Jalen Hurts ruled out after moving blood clot; Tanner McKee to start as Eagles confront pivotal stretch
The Eagles announced Jalen Hurts will miss Sunday’s game — and likely more time — after a follow-up ultrasound showed movement in a superficial blood clot in his calf.
By SLAM Intel Desk · 6 min read · Updated Oct 16, 2026, 5:42 PM EDT
Reported · Published
The 1–10 score is editorial significance. Measured changes below require source-linked records; the score does not claim a change in win probability or medical severity.
Lede — a sudden, consequential absence
The Eagles announced Thursday that Jalen Hurts will not play in Sunday’s home game against Carolina after a follow-up ultrasound showed movement in a superficial blood clot in his calf. The decision came after Hurts traveled with the team to London, played in that game and then underwent further imaging when doctors noted change in the clot’s position.
That single development has immediate and layered consequences: an on-field replacement for Sunday, an uncertain medical timeline for a star quarterback, and a consequential roster and trade-deadline calculus as Philadelphia tries to salvage a season that has already tilted off course.
Immediate impact: McKee inherits a fragile offense
Tanner McKee, the club’s backup, is expected to start in Week 6. McKee has limited NFL starting experience and brings a different skill set than Hurts; he’s a more traditional pocket passer, which will require schematic adjustments from the Eagles’ coaching staff.
Philadelphia (2-3) is coming off three straight losses and faces a compact stretch of NFC East opponents after Carolina. How McKee performs over the next several weeks will shape pressure on management to be buyers or sellers ahead of the trade deadline.
Why the medical detail changes the equation
A superficial clot found before the London trip was initially judged stable enough for Hurts to play. The deciding factor for the team’s recent announcement was that a follow-up ultrasound showed movement in the clot — a clinical finding that typically prompts more conservative treatment and closer monitoring.
That shift means the Eagles and league medical staff will prioritize Hurts’ long-term health over a quick return, and the team must plan roster moves without a clear recovery timetable.
Bigger-picture choices: patchwork or investment?
Hurts’ absence forces a strategic choice: either invest assets (salary cap room, draft capital, or a trade) to acquire an experienced starting QB for a short playoff window, or accept a stopgap approach, protect long-term assets and let McKee or another internal option bridge the gap.
Each path carries tradeoffs. Buying in can salvage a season if the player fits immediately, but it risks mortgage-like decisions if Hurts’ absence lasts or becomes prolonged. Standing pat preserves roster flexibility but could make a thin margin of error terminal in a competitive NFC East.
SLAM Explains
The complicated part, made simple.
What 'superficial blood clot' means for an NFL player
A superficial blood clot (typically in a calf vein) is different from a deep vein thrombosis (DVT). Movement of a clot on repeat imaging raises concern because it suggests instability; doctors commonly respond by starting anticoagulation and restricting activities until the clot stabilizes or resolves.
Why it matters here
The presence of a moving clot changes the medical calculus for allowing contact sports; teams and league doctors weigh the risk of embolism or clot propagation against the urgency to return a franchise quarterback to play.
Sources and attribution
- NFLPublished Oct 15, 2026, 1:11 PM EDT
Reporting attributed to NFL.
- CBS SportsPublished Oct 15, 2026, 3:28 PM EDT
Reporting attributed to CBS Sports.
- Yahoo SportsPublished Oct 15, 2026, 11:00 PM EDT
Reporting attributed to Yahoo Sports.
Take it to the engine
See the matchup intelligence.
Continue the story

